Royalty Pharma holder proposes $5.71M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Royalty Pharma plc is named in a notice for a proposed sale by SCH Investment Partners LLC of 100,000 Class A ordinary shares, with an aggregate market value of $5,709,000 and an approximate sale date of June 30, 2026. SCH Investment Partners LLC is listed under the issuer relationship “Officer.” The shares were acquired from the issuer in a private transaction on February 14, 2025. The proposed sales are in connection with a selling plan dated March 20, 2026, intended to comply with Rule 10b5-1(c). Christopher Hite signed the notice.
Key Figures
Key Terms
Rule 10b5-1(c) regulatory
private transaction financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.